Cardiac Involvement in Patients With Duchenne/Becker Muscular Dystrophy
NCT ID: NCT02470962
Last Updated: 2025-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
59 participants
OBSERVATIONAL
2015-06-01
2022-03-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Myocardial Involvement in Carriers of Duchenne Muscular Dystrophy: An MRI-study
NCT01712152
Prospective Becker-Heart-Study
NCT02020954
2D Strain Evaluation: Children With Duchenne Muscular Dystrophy Versus Healthy Children
NCT02418338
The Cardiovascular Genetic and Therapeutic Implications of Muscular Dystrophy
NCT00518817
Duchenne Muscular Dystrophy Heart Study
NCT03443115
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with muscular dystrophy
Boys aged 8 to 18 years with muscular dystrophy of the Duchenne / Becker type
No interventions assigned to this group
Children without heart disease
Children without heart disease, aged 8-18 years, as CMR comparison group
Observation
Observation by serial echocardiography with extended techniques and cardiac magnetic resonance imaging
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observation
Observation by serial echocardiography with extended techniques and cardiac magnetic resonance imaging
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent
Exclusion Criteria
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant or his/her parents or legal caregivers,
* Inability to lie still for the duration of the imaging procedures (approximately 45 minutes each for echocardiography and CMR)
* MR-incompatible implanted or accidentally incorporated metal device or claustrophobia that prohibits use of magnetic resonance imaging
8 Years
18 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Children's Hospital, Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barbara EU Burkhardt, MD
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital Zürich, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DMD-Herz
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.